Anxiety and depression symptoms after virological clearance of COVID‐19: A cross‐sectional study in Milan, Italy

Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID‐19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS‐A/D). 30% of patients displayed pathological HADS‐A/D, 52.4% showed persistent symptoms. Pathological pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Virol
Main Authors: Tomasoni, Daniele, Bai, Francesca, Castoldi, Roberto, Barbanotti, Diletta, Falcinella, Camilla, Mulè, Giovanni, Mondatore, Debora, Tavelli, Alessandro, Vegni, Elena, Marchetti, Giulia, d'Arminio Monforte, Antonella
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Short Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7461061/
https://ncbi.nlm.nih.gov/pubmed/32841387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.26459
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados